Will there be a whirlwind of new targets emerging?

It’s time to get back to basics – and also our roots – with a look at potential new targets and approaches that could emerge in the future.

Successful oncology new product development isn’t about the latest shiny new thing that’s in fashion, or everyone is following now, but is much more about the long term game of understanding the biology of disease, finding the gaps (opportunities) and developing new compounds faster than everyone else.

If truly we want to create blue ocean strategies then it begins with the science and builds out from there.

On the slate today we have four areas of interest that could yield new products or indications in the future.

To learn more from our latest analysis and get a heads up on our oncology insights, subscribers can log-in or you can click to gain access to BSB Premium Content.

This content is restricted to subscribers

Posted by